1. 116PA targeted genomic analysis uncovered a large spectrum of acquired resistance mechanisms to BRAF inhibitor therapy in metastatic melanoma patients. (5th March 2018) Authors: Louveau, B; Reger de Moura, C; Battistella, M; Sadoux, A; Chami, I; Caramel, J; Dalle, S; Dumaz, N; Lebbe, C; Mourah, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗